pyrroles has been researched along with Epilepsy in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcella, A; Esposito, V; Fucile, S; Martinello, K; Mascia, A; Morace, R; Sciaccaluga, M | 1 |
| Bhardwaj, V; Bharti, R; Das, P; Kumari, S; Mazumder, AG; Purohit, R; Singh, D; Tanwar, G | 1 |
| An, D; Chen, L; Men, C; Qi, M; Wang, Z; Xu, W; Zhan, Y; Zhou, L | 1 |
| Chońska, J; Dawidowski, M; Mika, W; Turło, J | 1 |
| Keppel Hesselink, JM | 1 |
| Sun, RP; Yang, L; Yin, P; Zhou, HY | 1 |
| SCOTT, DF | 1 |
| Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Yaris, E; Yaris, F | 1 |
| Chapman, J; Maggio, N; Segal, M; Shavit, E | 1 |
| Kaufman, J; Renz, RH; Smith, S; Sohler, A | 1 |
| Avoli, M; Mattia, D; Nagao, T; Rogawski, MA | 1 |
| DeCoster, MA; Tortella, FC | 1 |
| Dominiczak, MH; Murphy, MJ | 1 |
| Abe, S; Hashizume, T; Imamura, H; Kojima, H; Morishima, H; Nagano, R; Nakano, M; Nishimura, I; Ohtake, N; Sakuraba, S; Sato, H; Shimizu, A; Sugimoto, Y; Suzuki-Sato, C; Tsuchiya, Y; Yamada, K | 1 |
| Pezzola, A; Popoli, P; Sagratella, S; Scotti de Carolis, A; Zeng, YC | 1 |
| Bidard, JN; Gandolfo, G; Gottesmann, C; Lazdunski, M | 1 |
| Durkó, I; Huszák, I; Karsai, K | 1 |
| Beattie, AD; Beveridge, GW; Goldberg, A; Hope, E; Hunter, JA; Khan, SA; Smith, AW | 1 |
1 review(s) available for pyrroles and Epilepsy
| Article | Year |
|---|---|
Kappa opioids: therapeutic considerations in epilepsy and CNS injury.
Topics: Analgesics, Opioid; Animals; Anticonvulsants; Benzofurans; Central Nervous System Diseases; Epilepsy; Humans; Pyrroles; Pyrrolidines; Receptors, Opioid, kappa; Thiophenes | 1994 |
17 other study(ies) available for pyrroles and Epilepsy
| Article | Year |
|---|---|
Loss of constitutive functional γ-aminobutyric acid type A-B receptor crosstalk in layer 5 pyramidal neurons of human epileptic temporal cortex.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adolescent; Adult; Animals; Baclofen; Carbazoles; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Drug Resistant Epilepsy; Enzyme Inhibitors; Epilepsy; Epilepsy, Temporal Lobe; Female; GABA-B Receptor Agonists; Humans; Inhibitory Postsynaptic Potentials; Male; Middle Aged; Muscarinic Agonists; Neocortex; Patch-Clamp Techniques; Pertussis Toxin; Pilocarpine; Protein Kinase C; Pyramidal Cells; Pyrroles; Rats; Receptors, GABA-A; Receptors, GABA-B; Temporal Lobe | 2018 |
Target identification, screening and in vivo evaluation of pyrrolone-fused benzosuberene compounds against human epilepsy using Zebrafish model of pentylenetetrazol-induced seizures.
Topics: Animals; Anticonvulsants; Class I Phosphatidylinositol 3-Kinases; Coumarins; Disease Models, Animal; Drug Evaluation, Preclinical; Epilepsy; Gene Expression Profiling; Gene Expression Regulation; Humans; Molecular Docking Simulation; Pentylenetetrazole; Proto-Oncogene Proteins c-akt; Pyrroles; Signal Transduction; TOR Serine-Threonine Kinases; Zebrafish; Zebrafish Proteins | 2019 |
Transient receptor potential vanilloid 4 is involved in the upregulation of connexin expression following pilocarpine-induced status epilepticus in mice.
Topics: Animals; Connexin 43; Connexins; Epilepsy; Gap Junction beta-1 Protein; Hippocampus; Leucine; Male; Mice; Mice, Inbred ICR; Morpholines; Pilocarpine; Pyrroles; Status Epilepticus; Sulfonamides; TRPV Cation Channels | 2019 |
Novel fluorinated pyrrolo[1,2-a]pyrazine-2,6-dione derivatives: synthesis and anticonvulsant evaluation in animal models of epilepsy.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Epilepsy; Halogenation; Hydrocarbons, Fluorinated; Male; Mice; Molecular Structure; Pentylenetetrazole; Pilocarpine; Pyrazines; Pyrroles; Rats; Rats, Sprague-Dawley; Seizures; Structure-Activity Relationship | 2014 |
NS1209/SPD 502, A Novel Selective AMPA Antagonist for Stroke, Neuropathic Pain or Epilepsy? Drug Development Lessons Learned.
Topics: Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Epilepsy; Humans; Neuralgia; Pyrroles; Receptors, AMPA; Stroke; Tetrahydroisoquinolines; Treatment Outcome | 2017 |
Matrix metalloproteinase-9 may be a potential therapeutic target in epilepsy.
Topics: Animals; Anti-Bacterial Agents; Atorvastatin; Epilepsy; Gene Expression Regulation, Enzymologic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Matrix Metalloproteinase 9; Mice; Minocycline; Models, Biological; Neurons; Pyrroles; Rats; Seizures; Treatment Outcome | 2011 |
PORPHOBILINOGEN-LIKE CHROMOGENS IN URINE OF EPILEPTICS.
Topics: Diagnosis; Epilepsy; Humans; Indicators and Reagents; Metabolism; Naphthalenesulfonates; Porphobilinogen; Porphyrins; Pyrroles; Urine | 1965 |
Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman.
Topics: Adult; Anxiety Disorders; Apgar Score; Atorvastatin; Chronic Disease; Diabetes Complications; Epilepsy; Female; Gliclazide; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Hypoglycemic Agents; Infant, Newborn; Obesity, Morbid; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pyrroles; Rosiglitazone; Thiazolidinediones | 2004 |
Thrombin induces long-term potentiation of reactivity to afferent stimulation and facilitates epileptic seizures in rat hippocampal slices: toward understanding the functional consequences of cerebrovascular insults.
Topics: Afferent Pathways; Animals; Animals, Newborn; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Epilepsy; Glutamic Acid; Hemostatics; Hippocampus; Long-Term Potentiation; Male; Peptide Fragments; Potassium; Pyrroles; Quinazolines; Rats; Rats, Wistar; Receptor, PAR-1; Thrombin | 2008 |
Significance of hydroxyskatole and mauve factor excretion in schizophrenia.
Topics: Adult; Alcoholism; Chromatography, Thin Layer; Chronic Disease; Epilepsy; Furans; Humans; Indoles; Male; Middle Aged; Pyrroles; Schizophrenia | 1967 |
Potassium channel activators counteract anoxic hyperexcitability but not 4-aminopyridine-induced epileptiform activity in the rat hippocampal slice.
Topics: 4-Aminopyridine; Animals; Benzopyrans; Cromakalim; Diazoxide; Epilepsy; Hippocampus; Hypoxia, Brain; In Vitro Techniques; Male; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley | 1994 |
Efficacy of statin therapy: possible effect of phenytoin.
Topics: Anticholesteremic Agents; Atorvastatin; Cytochrome P-450 Enzyme System; Drug Interactions; Epilepsy; Female; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Middle Aged; Phenytoin; Pyrroles; Simvastatin | 1999 |
Discovery of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems.
Topics: Animals; Carbapenems; Convulsants; Dipeptidases; Drug Design; Epilepsy; Male; Mice; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Pyrroles; Rats; Rats, Sprague-Dawley; Staphylococcus aureus; Structure-Activity Relationship | 2000 |
Cromakalim (BRL 34915) counteracts the epileptiform activity elicited by diltiazem and verapamil in rats.
Topics: Animals; Anticonvulsants; Benzopyrans; Cromakalim; Diltiazem; Electric Stimulation; Electroencephalography; Epilepsy; Evoked Potentials; Hippocampus; In Vitro Techniques; Injections, Intraventricular; Male; Pentobarbital; Pyrroles; Rats; Rats, Inbred Strains; Synapses; Synaptic Transmission; Verapamil | 1991 |
K+ channels openers prevent epilepsy induced by the bee venom peptide MCD.
Topics: Animals; Antihypertensive Agents; Bee Venoms; Benzopyrans; Cromakalim; Epilepsy; Injections, Intraventricular; Male; Peptides; Potassium Channels; Pyrroles; Rats; Rats, Inbred Strains | 1989 |
Experimental data to the pathogenesis of cryptopyrrole excretion in schizophrenia, I.
Topics: Chromatography; Depression; Epilepsy; Humans; Mass Screening; Paranoid Disorders; Periodicity; Porphyrins; Psychotic Disorders; Pyrroles; Schizophrenia; Tryptophan | 1972 |
Hereditary coproporphyria. Photosensitivity, jaundice and neuropsychiatric manifestations associated with pregnancy.
Topics: Adolescent; Amino Acids; Epilepsy; Feces; Female; Fetal Death; Humans; Hypertension; Jaundice; Levulinic Acids; Liver Function Tests; Neurologic Manifestations; Photosensitivity Disorders; Porphyrias; Porphyrins; Postpartum Period; Pregnancy; Pregnancy Complications; Pyrroles; Skin Manifestations | 1971 |